|
|
||||||||


*
Department of Immunology, University of Strathclyde, Glasgow, Scotland;
Division of Infection and Immunity, Institute of Biomedical and Life Sciences, Joseph Black Building, University of Glasgow, Glasgow, Scotland;
Department of Pathology, Glasgow Royal Infirmary, Glasgow, Scotland; and
§
Department of Immunology, University of Glasgow, Western Infirmary, Glasgow, Scotland
Understanding the factors that control the differential induction
of Th1 and Th2 responses is a key immunologic objective with profound
implications for vaccination and immunotherapy of infectious and
autoimmune diseases. Using Ag formulated in lipid vesicles prepared
from nonionic surfactants, we describe a novel mechanism influencing
the balance of the Th1 or Th2 response. Our results indicate that
inoculation of BALB/c mice with vesicles with a mean diameter
225 nm
preferentially induces Th1 responses, as characterized by increased
titers of IgG2a in plasma and elevated IFN-
production by lymph node
cells. However, preparation of the same quantity of Ag in vesicles with
mean diameter of
155 nm induces a Th2 response, as identified by IgG1
in the absence of IgG2a production and increased lymph node IL-5
production. Although large (
225 nm) vesicles could induce IL-12
production, smaller vesicles (
155 nm) could not. However, small
vesicles did induce higher levels of IL-1ß production by macrophages
than larger vesicles. The role of IL-12 in this response was confirmed
in IL-12-deficient mice, whose spleen cells failed to produce IFN-
following in vivo priming with Ag prepared in large vesicles. Our
results therefore indicate that macrophages respond to endocytosis of
large or small vesicles by producing different patterns of cytokines
that can subsequently direct the immune response toward a Th1 or a Th2
phenotype.
This article has been cited by other articles:
![]() |
J. M. Brewer, K. G. J. Pollock, L. Tetley, and D. G. Russell Vesicle Size Influences the Trafficking, Processing, and Presentation of Antigens in Lipid Vesicles J. Immunol., November 15, 2004; 173(10): 6143 - 6150. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |